Listed

Arbutus Biopharma Corp

ABUSNasdaqCIK 1447028HealthcareFiscal year ends Dec 31

Reports and events: 561 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Arbutus Biopharma Corp, Reports and events
FiledFormWhat it isAccession number
2017-10-0310:32 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001104659-17-060416
2017-10-0308:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-005871
2017-09-2510:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-005701
2017-09-2508:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-005694
2017-09-2217:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-005685
2017-09-2012:38 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-005617
2017-09-1520:58 ETSC 13DOwnership report, active investor0001193125-17-285465
2017-09-0711:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-005435
2017-08-1413:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-005024
2017-08-0317:28 ET10-QQuarterly reportPeriod 2017-06-300001628280-17-008044
2017-08-0316:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-004691
2017-08-0116:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-004545
2017-07-2710:46 ET8-K1.02 Termination of a material agreement; 9.01 Financial statements and exhibits0001171843-17-004383
2017-07-0617:49 ETSC 13D/AOwnership report, active investor, amended0000903423-17-000447
2017-06-1417:29 ETSC 13D/AOwnership report, active investor, amended0000903423-17-000417
2017-06-0211:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-003427
2017-05-2613:36 ET8-K5.07 Shareholder vote results0000912282-17-000133
2017-05-2207:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-003229
2017-05-1716:56 ET10-K/AAnnual report, amendedPeriod 2017-03-310001628280-17-005644
2017-05-0417:23 ET10-QQuarterly reportPeriod 2017-03-310001628280-17-004968
2017-05-0416:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-002663
2017-05-0208:28 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-002480
2017-04-2516:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-002303
2017-04-1817:00 ETDEF 14AProxy statementPeriod 2017-04-180001628280-17-003789
2017-04-1308:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-002101
2017-03-2819:52 ET8-K8.01 Other events0001628280-17-002951
2017-03-2420:09 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001628280-17-002872
2017-03-2206:06 ET10-KAnnual reportPeriod 2016-12-310001628280-17-002760
2017-03-2107:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-17-001641
2017-03-2015:00 ET8-K/A1.01 Entry into a material agreement0001628280-17-002711
2017-03-1617:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-001586
2017-03-0609:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-001299
2017-02-0916:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-000795
2017-02-0806:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-17-000735
2016-12-2214:05 ET10-Q/AQuarterly report, amendedPeriod 2016-09-300000912282-16-000926
2016-12-1216:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-013604
2016-11-1416:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-013217
2016-11-0316:49 ET10-QQuarterly reportPeriod 2016-09-300001628280-16-020766
2016-11-0316:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001171843-16-012925
2016-10-1916:26 ETSC 13D/AOwnership report, active investor, amended0001104659-16-150928
2016-10-1916:13 ETSC 13DOwnership report, active investor0001104659-16-150919
2016-10-0610:22 ET8-K1.02 Termination of a material agreement; 5.02 Departure or appointment of officers or directors0000912282-16-000855
2016-10-0312:48 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-012347
2016-10-0307:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-012337
2016-09-2916:01 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-012315
2016-09-2813:53 ET8-K3.01 Delisting notice0000912282-16-000848
2016-09-1307:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-012137
2016-08-1914:23 ET8-K1.01 Entry into a material agreement0000912282-16-000805
2016-08-1008:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-011661
2016-08-0816:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001171843-16-011587

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 17:55 ET. Listed shows no prices and gives no investment advice.